Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lackingmdr1a-encoded P-glycoprotein
- 1 October 2000
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 29 (2) , 103-111
- https://doi.org/10.1002/1098-2744(200010)29:2<103::aid-mc7>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonucleasePublished by Elsevier ,2004
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cellsOncogene, 1999
- Multidrug resistance: molecular mechanisms and clinical relevanceCancer Chemotherapy and Pharmacology, 1997
- P-Glycoprotein — A Marker of Cancer-Cell BehaviorNew England Journal of Medicine, 1995
- Expression of P-Glycoprotein in High-Grade Osteosarcomas in Relation to Clinical OutcomeNew England Journal of Medicine, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Activation of distinct multidrug‐resistance (P‐glycoprotein) genes during rat liver regeneration and hepatocarcinogenesisMolecular Carcinogenesis, 1993
- Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas.Molecular and Cellular Biology, 1990
- Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic miceCell, 1989